Hadi Mohamad Abu Rasheed, Scientific Advisor at the Qatar Cancer Society and Adjunct Lecturer at the University of Doha for Science and Technology, shared a post by Personalised Cancer Care Alliance on LinkedIn, adding:
“Today, I am proud to participate in the launch of the Personalised Cancer Care Alliance (PCCA) Position Paper 2.0: From Theory to Practice.
This milestone is personally meaningful to me because I had the opportunity to contribute to the GCC chapter, particularly through the lens of Qatar’s experience and the role of Qatar Cancer Society in advancing people-centred cancer care.
For me, Personalised Cancer Care is not only about innovation, genomics, or advanced treatment pathways. It is also about making sure that cancer care reflects the real needs of patients, survivors, caregivers, and communities.
Through my work at Qatar Cancer Society, I continue to see how advocacy can shape better systems: raising awareness, reducing stigma, supporting early detection, strengthening patient navigation, improving psychosocial support, and ensuring that people affected by cancer are meaningfully included in decision-making.
The GCC chapter is an important step because it shows that patient organisations across Qatar, Kuwait, Saudi Arabia, and the UAE are not working at the margins of cancer control. We are becoming strategic partners in shaping policy, strengthening health literacy, improving access, and translating the Five Ps of Personalised Cancer Care into practice: Predictive, Preventative, Participatory, Personalised, and Pre-emptive care.
I am grateful to have been part of this collective regional effort and proud to represent Qatar’s contribution to this important agenda.
My commitment moving forward is clear: to continue strengthening my role in Personalised Cancer Care advocacy, support regional collaboration, and help ensure that patient voices are not only heard, but embedded in cancer policy and practice across the GCC.
Thank you to International Alliance of Patients’ Organizations (IAPO), AlignnEficient Health Consultancies, Dani Mothci, Dr. Sawsan AlMadhi and all partners and patient advocates who contributed to this important work.”
Quoting Personalised Cancer Care Alliance‘s post:
“Its now 1 day to go till our our upcoming Personalised Cancer Care Alliance (PCCA) event From Theory to Practice: PCCA Position Paper 2.0 Launch, taking place next week.
Don’t miss your chance to join this milestone gathering to launch the Personalised Cancer Care Alliance Position Paper 2.0, building on the first Position Paper published in 2022.
Date: Tuesday, 5 May 2026
Time: 3:00 – 4:30 pm (GST)
Format: Online via zoom
Language: English with simultaneous interpretation into Arabic
Register your place here.
This newly updated position paper recognises that advocacy must move from theory to practice and highlights two pilot initiatives launched to test the recommendations from the first position paper in real-world contexts.
As a result, the Position Paper 2.0 marks a critical shift from conceptual advocacy to implementation-driven action, grounded in real-world evidence, lived experiences, and multi-stakeholder collaboration.
Speakers include:
Dani Mothci – CEO, International Alliance of Patients’ Organizations (IAPO)
Hajar Gdader – Advocacy Strategy Lead, NABD-BC2 Association
Khaled Al-Saleh – Secretary General and Board Chair, Society for Smoking and Cancer Prevention
Reem Al-Ajlouni – Director, Jordan Breast Cancer Program
Majed Mohamed – Head of Community Engagement & Advocacy Department, Friends of Cancer Patients
Heba AlSawahli – Consultant, WHO
Claire Lebled – EEMEA Regional Patient Engagement Lead, MSD
Learn more and register your place here.”
Other articles featuring Hadi Mohamad Abu Rasheed on OncoDaily.